Clinical implementation of precision medicine

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

In the end of last year, the US Food and Drug Administration has announced the authorization of MSK-IMPACT, clinical test based on multiplex cancer panel profiling for genetic mutations and other alterations in patients' tumors, while in Japan, NCC Oncopanel, domestic multiplex cancer panel, is scheduled to be clinically implemented as advanced medical care B in this coming spring, chasing the state of the art technology for cancer treatment. In this article, we outline a recently published roadmap for precision medicine in Japan, together with our years of experience on cancer diagnosis and treatment based on multiplex cancer panel at Okayama University Hospital and Okadai Biobank.

Original languageEnglish
Pages (from-to)601-604
Number of pages4
JournalJapanese Journal of Cancer and Chemotherapy
Volume45
Issue number4
Publication statusPublished - Apr 2018

Keywords

  • Cancer treatment
  • Genetic mutation
  • Multiplex cancer panel
  • Precision medicine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Clinical implementation of precision medicine'. Together they form a unique fingerprint.

Cite this